A group of researchers investigated single-molecule electrical detection of ribonucleic acid (RNA) cancer biomarkers.
Clearmind Medicine Concludes the Successful Participation in the Psychedelic Medicine – Israel 2024 Conference: Presented Industry Leaders its Groundbreaking Research | Psychedelic Invest
Vancouver, Canada, July 31, 2024 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on discovery and development of